In experimental candidiasis with secondary immunodeficiency, the disease course was less severe after thymogen injections.
In plain wordsIn animals with experimental candidiasis and reduced immunity, the disease was less severe after thymogen injections.
- Peptide
- Thymogen (oglufanide)
- Outcome
- DecreaseCandidiasis severity
- Study
n: not reported in source
Candidiasis with secondary immunodeficiency- Outcome group
- Infection and antimicrobial activity · Infection
- Studied dose
- Dose not stated · injectionAs given in this study.
Source sentences
Experimental candidiasis developing against the background of the secondary immunodeficiency is described. After thymogen injections the course of candidiasis proceeds less severely, this suggesting that thymogen activates the immunocompetent system, including thymus, favouring the disappearance of…